Skip to main content
search
Category

Investors

MedinCell’s partner Teva provides guidance for UZEDY in 2024 and an update on olanzapine LAI (mdc-TJK)

 January 31, 2024
January 31, 2024

Teva announces recruitment completion of phase 3 clinical study of mdc-TJK

 January 9, 2024
January 9, 2024

Jefferies initiates MedinCell’s coverage with a “Buy” recommendation

 January 4, 2024
January 4, 2024

Half-Year results (April 2023 – September 2023)

 December 19, 2023
December 19, 2023

MedinCell applauds Teva and Royalty Pharma collaboration to further accelerate olanzapine LAI program

 November 13, 2023
November 13, 2023

MedinCell at the 2023 Jefferies Global Healthcare Conference -London, 14-16 November

 November 6, 2023
November 6, 2023

MedinCell and the European Investment Bank (EIB) have replaced a financial covenant of their ongoing loan agreement to better fit with MedinCell business model

 October 3, 2023
October 3, 2023

Better medicine for all

© 2024 Medincell. All rights reserved.

Website by ScreenUp